The Science Journal of the American Association for Respiratory Care

2008 OPEN FORUM Abstracts


Edward Conway1, Sue Brungs1, Lisa Devoto1, Diane Herzog1

Background: Asthma is the most common chronic childhood disease, which is the main reason for emergency visits and hospital admissions. Re-admission rates in these patients is also recognized as being high, Cincinnati Children's recognized in May, 2006 our re-admission rate at seven days post discharge was 15%, at thirty days our re-admission rate was at 38%. The most common reason for these re-admission rates is a lack of adherence to treatment regiments prescribed. Studies have shown that children with chronic disease despite education may not be following prescribed treatment regiments.
The aim at Cincinnati Children's is to reduce the re-admission rate for children with asthma, by providing a standardized asthma education packet, from Monahagn Medical, "Doc Monahagn", and an asthma action plan.

In May of 2006 we instituted the use of the asthma action planned which was developed by a multi-disciplinary team. The asthma action plan will provide the patients and parents a resource for taking their medications. In September of 2006 all of the RT's completed competencies on medication delivery to ensure parents and patients are hearing a consistent message on how to properly take/give medications. In Jan of 2007 pharmacy set up a labeling system for patients to take home the Albuterol MDI which patients were using in the hospital, this ensured that patients will have proper medications at time of discharge. In July of 2007 we instituted the use of the Doc Monahagn education packet. With these systems in place upon admission to the asthma unit, patients and parents receive detailed asthma education.

Data collection included tracking patient from May of 2006 through December of 2007 with a total of 297 patients. We looked at visits back to Cincinnati Children's after discharge as re-admissions, emergency room visit, and clinic visit receiving an Albuterol treatment. We looked at a seven day and thirty day period. Within our seven day follow up, patients re-admission rate went from 15% to 0%. Patients returning to the emergency room went from 15% to 0% and those returning to clinic and receiving an Albuterol treatment went from 30% in March 2007 to 10% in December of 2007. Within the thirty day return visit, the re-admission rate went from 38% to 0%, return visits to the emergency room went from 18% to 0%, and returning to clinic and receiving an Albuterol Treatment 15% to 20%.